Could blocking GLP-1 stop dangerous low blood sugar in type 1 diabetes?
NCT ID NCT07373236
First seen Jan 29, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study looked at whether blocking a hormone called GLP-1 can help people with type 1 diabetes release glucagon, a natural safeguard against low blood sugar. Researchers gave 12 adults with type 1 diabetes a substance to block GLP-1 and measured their glucagon levels during low blood sugar. The goal was to see if this approach could reduce the risk of severe hypoglycemia, a common and dangerous complication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gentofte Hospital
Hellerup, 2100, Denmark
Conditions
Explore the condition pages connected to this study.